{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:43:18Z","timestamp":1789803798630,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002631","name":"Gachon University","doi-asserted-by":"publisher","award":["GCU-2015-5106"],"award-info":[{"award-number":["GCU-2015-5106"]}],"id":[{"id":"10.13039\/501100002631","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea Health Technology R&D Project"},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute (KHIDI)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI14C1135"],"award-info":[{"award-number":["HI14C1135"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cellsig.2016.03.015","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T14:18:33Z","timestamp":1459693113000},"page":"788-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Bortezomib attenuates palmitic acid-induced ER stress, inflammation and insulin resistance in myotubes via AMPK dependent mechanism"],"prefix":"10.1016","volume":"28","author":[{"given":"Hyun Jeong","family":"Kwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Eun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Kyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-An","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyae Gyeong","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2016.03.015_bb0005","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1200\/JCO.2006.07.9665","article-title":"Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma","volume":"24","author":"Fisher","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0010","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma","volume":"348","author":"Richardson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0015","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-03-0781","article-title":"Approval summary for bortezomib for injection in the treatment of multiple myeloma","volume":"10","author":"Bross","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/med.20111","article-title":"Proteasome inhibitors: poisons and remedies","volume":"28","author":"Meiners","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0025","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0030","first-page":"255","article-title":"The ubiquitin\u2013proteasome system and its role in inflammatory and autoimmune diseases","volume":"3","author":"Wang","year":"2006","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2337\/db11-1652","article-title":"Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver","volume":"62","author":"Otoda","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.cellsig.2012.10.004","article-title":"Bortezomib\/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cell","volume":"25","author":"Selimovic","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2014.00213","article-title":"A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress","volume":"8","author":"Chaudhari","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0050","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Endoplasmic reticulum stress links obesity, insulin action and type 2 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0055","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease","volume":"140","author":"Hotamisligil","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0060","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s00125-007-0816-8","article-title":"The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients","volume":"50","author":"Marchetti","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0065","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.freeradbiomed.2006.03.003","article-title":"Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells","volume":"40","author":"Meiners","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0070","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1073\/pnas.94.3.855","article-title":"Activation of the cell death program by inhibition of proteasome function","volume":"94","author":"Drexler","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0075","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.20807","article-title":"Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL","volume":"42","author":"Ganten","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0080","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s10753-012-9454-5","article-title":"Inhibition of titanium particle-induced inflammation by the proteasome inhibitor bortezomib in murine macrophage-like RAW264.7 cells","volume":"35","author":"Mao","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0085","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1074\/jbc.M212307200","article-title":"A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids","volume":"278","author":"Chavez","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1039\/C0MB00089B","article-title":"Novel use of fluorescent glucose analogues to identify a new class of triazine-based insulin mimetics possessing useful secondary effects","volume":"7","author":"Jung","year":"2011","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0095","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"Goldberg","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0100","doi-asserted-by":"crossref","first-page":"24847","DOI":"10.1074\/jbc.M910284199","article-title":"Inhibitory and stimulatory effects of lactacystin on expression of nitric oxide synthase type 2 in brain glial cells. The role of Ikappa N-beta","volume":"275","author":"Stasiolek","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1096\/fj.03-0054com","article-title":"Long term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin\u2013proteasome pathway","volume":"18","author":"Stangl","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0110","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-kappaB activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0115","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00109-009-0469-9","article-title":"Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system","volume":"87","author":"Ludwig","year":"2009","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/thoraxjnl-2011-200717","article-title":"Proteasomal inhibition after injury prevents fibrosis by modulating TGF-\u03b2(1) signaling","volume":"67","author":"Mutlu","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.fct.2014.01.027","article-title":"Multiple pathways are involved in palmitic acid-induced toxicity","volume":"67","author":"Park","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0130","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1242\/jcs.026062","article-title":"Initiation and execution of lipotoxic ER stress in pancreatic \u03b2 cells","volume":"121","author":"Cunha","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2337\/diabetes.50.2.315","article-title":"Lipotoxicity of pancreatic \u03b2 cell is associated with glucose-dependent esterification of fatty acids into neutral lipids","volume":"50","author":"Briaud","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0140","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1210\/en.2009-1122","article-title":"Palmitate attenuated insulin signaling and induces endoplasmic reticulum stress and apoptosis in hypothalamic neurons: rescue of resistance and apoptosis through adenosine 5\u2019 monophosphate-activated protein kinase activation","volume":"151","author":"Mayer","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0145","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1210\/en.2010-1369","article-title":"Oleate blocks palmitate-induced abnormal lipid distribution, endoplasmic reticulum expansion and stress, and insulin resistance in skeletal muscle","volume":"152","author":"Peng","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0150","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s001250050822","article-title":"NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X","volume":"40","author":"Pickup","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0160","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1074\/jbc.M708700200","article-title":"Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells","volume":"283","author":"Coll","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/icb.2014.16","article-title":"From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation","volume":"92","author":"Pal","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrendo.2012.49","article-title":"Muscles, exercise and obesity: skeletal as a secretory organ","volume":"8","author":"Pedersen","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbrc.2014.02.008","article-title":"Bortezomib inhibits C2C12 growth by inducing cell cycle arrest and apoptosis","volume":"445","author":"Xing","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0180","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinase: conserved guardians of cellular energy","volume":"8","author":"Hardie","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0185","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s00125-013-2867-3","article-title":"Oleate prevents saturated-fatty acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism","volume":"56","author":"Salvado","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0190","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1007\/s00125-014-3331-8","article-title":"PPAR\u03b2\/\u03b4 prevents endoplasmic stress-associated inflammation and insulin resistance in skeletal muscle cells through AMPK-dependent mechanism","volume":"57","author":"Salvado","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.cellsig.2016.03.015_bb0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00280-014-2451-7","article-title":"Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells","volume":"74","author":"Min","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cellsig.2016.03.015_bb0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.taap.2015.04.001","article-title":"The proteasome inhibitor bortezomib induces testicular toxicity by upregulation of oxidative stress, AMP-activated protein kinase (AMPK) activation and deregulation of germ cell development in adult murine testis","volume":"285","author":"Li","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656816300675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656816300675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T14:54:19Z","timestamp":1536850459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656816300675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0898656816300675"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2016.03.015","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bortezomib attenuates palmitic acid-induced ER stress, inflammation and insulin resistance in myotubes via AMPK dependent mechanism","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2016.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}